Four PegLyte powder lots recalled nationwide over possible foreign matter
Health Canada’s notice lists lots 260303 through 260306, DIN 00777838, in a retailer-level Type III recall by Pendopharm.
In this article & details
Pendopharm is recalling four lots of PegLyte powder for solution across Canada because they may contain foreign matter, according to Health Canada’s November 17 notice.
The affected lots are 260303, 260304, 260305 and 260306. All are listed under DIN 00777838. The recalling firm is Pendopharm Division of Pharmascience Inc., based in Montréal.
Notice identifies the formulation and recall level
The product contains macrogol 238.18 g, potassium chloride 3.05 g, sodium bicarbonate 6.76 g, sodium chloride 5.85 g and sodium sulfate 22.96 g. The action is a Type III recall at the retailer level, identification number RA-82964.
The notice does not describe the foreign matter, identify its origin or quantify affected packages. Its product table specifies the four lots rather than every PegLyte package.
Health Canada asks people to verify whether their product is affected and consult their health-care provider before discontinuing it or about health concerns. Questions about the recall can be directed to the company. The department also requests reports of side effects and other health-product safety complaints.
References
- PegLyte Powder: Affected lots may contain foreign matter — Health Canada, November 17, 2026; recall RA-82964